TATVA Tatva Chintan Pharma Chem Ltd Other Situations Announcement 2024 - IPO Fund Utilization Tatva Chintan Pharma Chem Ltd confirmed that there have been no deviations in the utilization of funds raised through its IPO, which totaled Rs. 2250 million, and reported that their Dahej Manufacturing Facility expansion has been completed at a revised cost of Rs. 1,529.35 million, funded by internal accruals..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Tatva Chintan Pharma Chem Ltd